Clinical trial
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5…
NCT00356369 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00356369 |
|---|---|
| Title | Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine |
| Official title | Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal |
| Intervention type | Biological |
| Interventions | meningococcal ACWY (vaccine), Mencevax™ ACWY |
| Enrollment | 500 |
| Start date | Dec 23, 2006 |
| Primary completion | Sep 7, 2007 |
| Completion | Feb 28, 2008 |
| First posted | Jul 26, 2006 |
| Last update posted | Jul 3, 2018 |
| Countries | Philippines, Saudi Arabia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: